| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-05 |